Skip to main content
CRNX
NASDAQ Life Sciences

Vertex to Acquire Crinetics Pharmaceuticals in Major Pharma Deal

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$42.03
Mkt Cap
$4.432B
52W Low
$25.83
52W High
$57.99
52W Position info
63% above low
Off High info
28% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

CRNX sits 63% above its 52-week low of $25.83.

Summary

Vertex Pharmaceuticals has announced its intent to acquire Crinetics Pharmaceuticals for $10 billion, offering $85 a share in cash. This major M&A event follows strong positive news for Crinetics, including European Commission approval for its key drug PALSONIFY, robust Q1 2026 financial results with significant product revenue growth, and positive long-term clinical data presentations for PALSONIFY. The acquisition represents a strategic expansion for Vertex, which anticipates the deal will immediately help revenue growth and contribute to non-GAAP operating income by 2029. Vertex projects Crinetics's PALSONIFY and Atumelnant could potentially add more than $5 billion in combined annual revenue. The deal is expected to fundamentally change Crinetics' investment profile, likely at a premium for its shareholders.

At the time of this announcement, CRNX was trading at $42.03 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.4B. The 52-week trading range was $25.83 to $57.99. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

CRNX - Latest Insights

CRNX
Sep 01, 2026, 9:26 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $84.97
Real-time Price: $84.97 info
Change: $0 (0%) info
Market Cap: $9.01B info
CRNX
Aug 28, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $84.84
Real-time Price: $84.97 info
Change: +$0.130 (+0.15%) info
Market Cap: $9.01B info
CRNX
Aug 19, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $84.70
Real-time Price: $84.97 info
Change: +$0.270 (+0.32%) info
Market Cap: $9.01B info
CRNX
Aug 14, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $84.41
Real-time Price: $84.97 info
Change: +$0.560 (+0.66%) info
Market Cap: $9.01B info
CRNX
Aug 03, 2026, 4:22 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $83.76
Real-time Price: $84.97 info
Change: +$1.21 (+1%) info
Market Cap: $9.01B info